4//SEC Filing
Sawicki Mark W 4
Accession 0001104659-24-036284
CIK 0001124524other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 7:50 PM ET
Size
14.8 KB
Accession
0001104659-24-036284
Insider Transaction Report
Form 4
Cryoport, Inc.CYRX
Sawicki Mark W
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2024-03-09+2,666→ 75,791 total - Sale
Common Stock
2024-03-15$15.43/sh−1,312$20,247→ 73,061 total - Award
Common Stock
2024-03-15+5,750→ 78,811 total - Exercise/Conversion
Restricted Stock Rights
2024-03-09−2,666→ 2,667 total→ Common Stock (2,666 underlying) - Award
Stock Option (right to buy)
2024-03-15+11,500→ 11,500 totalExercise: $16.70Exp: 2031-03-15→ Common Stock (11,500 underlying) - Sale
Common Stock
2024-03-11$16.35/sh−1,418$23,188→ 74,373 total
Footnotes (5)
- [F1]Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
- [F2]Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
- [F3]Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025.
- [F4]The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024.
- [F5]1/48 of options vest on the 15th of each month for forty-eight months beginning April 25, 2024.
Documents
Issuer
Cryoport, Inc.
CIK 0001124524
Entity typeother
Related Parties
1- filerCIK 0001848218
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 7:50 PM ET
- Size
- 14.8 KB